| Name | 3-Cyano-4-({3-[2-({[2-(4-piperidinyl)ethyl]amino}methyl)-4-pyridinyl]-3'-(trifluoromethyl)-4-biphenylyl}oxy)-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide |
|---|---|
| Synonyms |
PF-06456384 3hcl
3-Cyano-4-[[3-[2-[[[2-(4-piperidinyl)ethyl]amino]methyl]-4-pyridinyl]-3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]oxy]-N-1,2,4-thiadiazol-5-yl-benzenesulfonamide trihydrochloride Benzenesulfonamide, 3-cyano-4-[[3-[2-[[[2-(4-piperidinyl)ethyl]amino]methyl]-4-pyridinyl]-3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]oxy]-N-1,2,4-thiadiazol-5-yl-, hydrochloride (1:3) 3-Cyano-4-((3-(2-(((2-(piperidin-4-yl)ethyl)amino)methyl)pyridin-4-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)oxy)-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide trihydrochloride |
| Description | PF-06447475 trihydrochloride is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively. PF-06447475 trihydrochloride can be used for parkinson's disease (PD) research[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 789.8±70.0 °C at 760 mmHg |
| Molecular Formula | C35H32F3N7O3S2 |
| Molecular Weight | 719.799 |
| Flash Point | 431.4±35.7 °C |
| Exact Mass | 719.195984 |
| LogP | 6.95 |
| Vapour Pressure | 0.0±2.8 mmHg at 25°C |
| Index of Refraction | 1.666 |